Acumen Pharmaceuticals, Inc. Common Stock
XNAS:ABOS
1.89
$1.91 - 68.00
$1.89 - 12.00
$1.85
$1.95
$1.86
$1.86
2.46
0.86
49521
155088.5
47788354.18
Chart
TendieTensor AI Analysis
Company
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
Fundamentals
52
-0.840000
1.209220
-0.44
100
BBG0058YJ317
BBG0058YJ326
60.57M
60.57M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own ABOS. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.